Evaluation of alternative clinical samples for the detection of SARS-CoV-2 and influenza virus by automated multiplex RT-PCR
DOI:
https://doi.org/10.3855/jidc.20801Keywords:
SARS-CoV-2, influenza A, RT-PCR, saliva, nasal, nasopharyngealAbstract
Introduction: The aim of this study was to compare the performance of different clinical specimens—nasopharyngeal (NP) swabs collected by healthcare professionals (HCP-NP), self-collected nasal swabs (Sc-N), and saliva samples (S)—in diagnostic tests for investigating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and influenza A/B RNA.
Methodology: These clinical samples were collected from 404 symptomatic cases and tested with the SARS-CoV-2 and influenza A/B RNA tests on the cobas 6800 System of Roche Molecular Systems (Roche Molecular Systems, Pleasanton, USA). The SARS-CoV-2 or influenza virus infection status was determined for all patients based on the predefined criteria and corresponding algorithms. Positive and negative predictive values (PPV, NPV), sensitivity, specificity, coefficient of variation (CV), interrater reliability, correlation, ,and days of sample collection of these three sample types were analyzed.
Results: There was almost perfect agreement between the these sample types for the diagnosis of SARS-CoV-2 and influenza A. The overall performance (PPV, NPV, sensitivity) and reproducibility (CV ≤ 6%) were favorable. Additionally, they showed similar trends for days of sample collection.
Conclusions: Diagnostic detection of SARS-CoV-2 and influenza RNA from Sc-N and S samples was comparable to HCP-NP samples. Using these samples would provide an advantage in diagnosing SARS-CoV-2 and influenza A infection, as they can be easily collected without the need for viral transport media.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Muhammed Alper Özarslan, Ömür Mustafa Parkan, Mehmet Soylu, Oğuzhan Acet, Selma Gökahmetoğlu, Zeynep Türe Yüce, Gamze Kalın Ünüvar, Seyfi Durmaz, Deniz Akyol, Feyza İzci Çetinkaya, Pınar Sağıroğlu, Gözde Akkuş Kayalı, Isabel Raika Durusoy, Ayşin Zeytinoğlu, Mustafa Altay Atalay, Meltem Taşbakan, Candan Çiçek, Orhan Yıldız, Hüsnü Pullukçu, Şaziye Rüçhan Sertöz, Selda Erensoy

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Funding data
-
Roche Diagnostics
Grant numbers Protocol number: 2020-11-12T14_12_01

